SCHEMBL2492329

SCHEMBL2492329

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
BACE1 P56817 2/20 0.43
ALOX5 P09917 1/20 0.42
BCL2L1 Q07817 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HNF4A P41235 1/20 0.41
PDE4B Q07343 5/20 0.40
PDE4A P27815 4/20 0.40
PDE4C Q08493 4/20 0.40
PDE4D Q08499 4/20 0.40
ESR2 Q92731 1/20 0.38
PTPN1 P18031 1/20 0.35
HSP90AB1 P08238 1/20 0.35
MAPT P10636 2/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4647831 0.84 HDAC4 (0.54) HDAC4HDAC2HDAC8HDAC6BACE1
SCHEMBL4870784 0.80 LMNA (0.39) HDAC4HDAC2HDAC8HDAC6BACE1
SCHEMBL949284 0.78 BACE1 (0.52) HDAC4HDAC2HDAC8HDAC6BACE1
SCHEMBL7005547 0.78 HDAC4 (0.54) HDAC4HDAC2HDAC8HDAC6BACE1
SCHEMBL3976573 0.77 HDAC4 (0.61) HDAC4HDAC2HDAC8HDAC6BACE1
SCHEMBL27749305 0.75 CYP2A6 (0.46) HDAC4HDAC2HDAC8HDAC6BACE1
Ethane SCHEMBL27298270 0.75 BACE1 (0.48) HDAC4HDAC2HDAC8HDAC6BACE1
SCHEMBL2489466 0.75 ALOX5AP (0.35) HDAC4HDAC2HDAC8HDAC6BACE1
SCHEMBL5595212 0.75 ALDH1A1 (0.46) HDAC4HDAC2HDAC8HDAC6BACE1
SCHEMBL2490178 0.75 BRD4 (0.38) BACE1ALOX5PDE4BPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH HDAC4 2018/4885HDAC2 924/4885HDAC8 1044/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 HDAC4 2257/4885HDAC2 962/4885HDAC8 1374/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R HDAC4 2106/4885HDAC2 887/4885HDAC8 1281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.